Codes ATC:
L01AA01
EMLc
Indication
Ewing sarcoma of bone and articular cartilage of unspecified sites
Code ICD11:
2C22.Z
INN
Cyclophosphamide
Type de médicament
Chemical agent
Type de liste
Liste complémentaire
(EML)
(EMLc)
(EMLc)
Formulations
Parenteral > General injections > IV:
500 mg in vial powder for injection ;
1 g in vial powder for injection ;
2 g in vial powder for injection
Oral > Solid > dosage form: 25 mg ; 50 mg
Oral > Solid > dosage form: 25 mg ; 50 mg
Historique des statuts LME
Sexe
Tous
Âge
Aussi recommandé pour les enfants
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
Résumé des preuves et recommandation du comité d'experts
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended the listings for oral dosage forms of cyclophosphamide on the EML and EMLc be amended to replace 'tablet' with 'solid oral dosage form' to reflect the availability also of capsules and allow greater flexibility in procurement.